The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

April 1, 2015 • By Jennifer Stichman, MD, and Dennis J. Boyle, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In some cases, medications are perceived as being ineffective. Many RA medications take months to reach full efficacy. Patients in remission sometimes stop their medications. It’s incumbent on us to outline the time line for a sufficient trial of medication and to teach that remission is not synonymous with cure.

You Might Also Like
  • Personal Beliefs Affect Medication Adherence for RA Patients
  • Medication Adherence for Osteoporosis Prevention
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
Explore This Issue
April 2015

Initiation of urate-lowering therapy is another time that anticipatory counseling can make a difference: It may be hard to convince a patient who flares after starting allopurinol that this is a medicine that really treats gout! Preemptive discussion of the potential to have flares may prevent self-discontinuation of the medication.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Importantly, patients are less likely to take medications if they hold beliefs or have concerns that conflict with the provider’s beliefs and concerns. Factors that drive rheumatologists to change medication regimens in rheumatoid arthritis are what we expect—swollen joint counts, physician global assessment, worsening erosions and increased disease activity compared with the prior visit. In contrast, when patients were asked what may lead them to escalate care, they cite painful joint counts, current physical functioning, satisfaction with current DMARDs and trust in their rheumatologist.8 Exploration of patient values and preferences around illness and medication can help tease out if patients are likely to be taking a prescribed regimen.

What Can We Do about It?

Improving adherence in chronic disease is challenging. Interventions that have been studied and found helpful almost all require a substantial amount of effort and resources. These interventions have to be continued indefinitely, because there is no evidence that low adherence can be “cured.”9

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One step that can be taken is to simplify dosage regimens when possible. Are there any medications that can be discontinued? Is a long-acting version available to decrease the dosing frequency?

Also, we should spend time on the front end to elicit patient concerns and make sure we are connected to the patient so they can share their fears and concerns.

Employing the teach-back method at the end of a visit is an excellent way to ensure patient understanding. One might say to the patient at the end of a visit, “What are you going to tell your spouse about our conversation and what medications you will be taking?” This technique can reveal important gaps in patient understanding.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Writing down the diagnosis highlights and medicine regimens may also improve education and retention.

Communication is at the heart of the adherence issue. The best predictor of adherence is the clinician–patient relationship. You need to understand the patient’s own belief about their illness. You need to show empathy by using good body language and by voicing concern about how the disease is affecting the patient.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Drug Updates, Rheumatoid Arthritis, Safety Tagged With: adherence, Boyle, Medication, patient care, rheumatology, StichmanIssue: April 2015

You Might Also Like:
  • Personal Beliefs Affect Medication Adherence for RA Patients
  • Medication Adherence for Osteoporosis Prevention
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • Gout Treatments Effective If Patients Maintain Lifelong Adherence to Therapies

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)